The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 330.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 358.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Purchase of new London Hotel

16 Feb 2023 07:00

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Purchase of new London Hotel 16-Feb-2023 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 

Dalata Hotel Group announces purchase of new London hotel for £44.3 million

The Group’s first Maldron Hotel in London

 

ISE: DHG              LSE: DAL

Dublin and London | 16 February 2023: Dalata Hotel Group plc ("Dalata" or "the Group"), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, is pleased to announce the addition of a new 192-bedroom hotel at 240 Seven Sisters Road, Finsbury Park, North London to its hotel portfolio. Under the transaction, Dalata has acquired the entire issued share capital of Tide Developments (4) Limited (“TD4”) for a total consideration of £44.3 million (€49.7 million) from Furadino Holdings Limited. TD4 has a gross asset value of £45.1 million and owns the freehold interest of the hotel property. The total consideration will be financed from Dalata’s existing cash and banking facilities.

The newly finished hotel, which has never traded, consists of 192 bedrooms, ground floor lobby and a restaurant and bar. Prior to opening in summer 2023, Dalata will invest in excess of £2 million to enhance the property and launch under the Maldron brand. The hotel, with an expectation of stabilised annual earnings of £4 million, will be Dalata’s first Maldron hotel in London, its 18th hotel in the UK and will create over 50 jobs locally. Conveniently located within walking distance of the Emirates Stadium, the hotel is adjacent to Finsbury Park Station, with extensive National Rail, London Underground and bus services offering direct links to King’s Cross St Pancras and the centre of London.

The property was constructed using the Vision Modular System, which can result in as much as a 40 per cent saving in the embodied carbon emissions when compared with traditional methods of construction. The sustainably designed hotel is BER A rated, includes photovoltaic panels, and is expected to achieve BREEAM ‘Excellent’ accreditation.

Dermot Crowley, CEO, Dalata commented on the announcement:

“London is a key strategic growth market for Dalata. We are very excited to be opening our first Maldron hotel in the city in advance of our Maldron in Shoreditch which is currently under construction. This acquisition represents an outstanding opportunity to operate a new, sustainably built, hotel in a vibrant and developing area as we continue our ambitious UK expansion plan. The strength of our balance sheet has been a crucial element in enabling us to make this investment as we continue to create value for all of our stakeholders.”

Shane Casserly, Corporate Development Director, Dalata added:

“Acquiring a new hotel asset in London, in challenging funding markets, that will be operational in the summer of 2023, is a fantastic achievement by the Group. This transaction highlights our appetite for growth as well as the flexibility of our business model, which enables us to grow through acquisition, development and leasing. We are excited by the excellent sustainability credentials of the property as we continue to make progress on our ambitious targets.”

ENDS

 

About Dalata

Dalata Hotel Group plc was founded in August 2007, listed as a plc in March 2014 and is now Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group operates two primary hotel brands, Clayton Hotels and Maldron Hotels. The Group’s portfolio comprises 50 primarily 4-star hotels situated in city-centre locations with over 10,950 rooms across 29 owned hotels, 18 leased hotels and three management contracts. The Group has ambitious expansion plans for the UK and continental Europe with a committed pipeline of over 1,300 rooms. For the first six months of 2022, Dalata reported revenue of €220.2 million and a profit after tax of €46.7 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

 

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Shane Casserly, Corporate Development Director

Carol Phelan, CFO

 Graham White, Head of Investor Relations

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

__________________________

 

 


ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:ACQ
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:223503
EQS News ID:1561077
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Feb 20183:40 pmRNSHolding(s) in Company
1st Feb 201810:41 amRNSTotal Voting Rights
12th Jan 20187:00 amRNSNotice of Results
2nd Jan 20189:14 amRNSTotal Voting Rights
27th Dec 20177:00 amRNSHolding(s) in Company
21st Dec 20173:26 pmRNSHolding(s) in Company
19th Dec 20177:00 amRNSYear End Trading Update
7th Dec 20175:52 pmRNSHolding(s) in Company
6th Dec 20173:44 pmRNSHolding(s) in Company
5th Dec 201711:40 amRNSTotal Voting Rights
29th Nov 20175:13 pmRNSHolding(s) in Company
22nd Nov 20174:58 pmRNSAgreement
7th Nov 201710:15 amRNSSigned A New Lease Agreement
7th Nov 20177:00 amRNSCapital Markets Day
1st Nov 20179:44 amRNSTotal Voting Rights
25th Oct 20173:42 pmRNSHolding(s) in Company
4th Oct 20174:32 pmRNSHolding(s) in Company
2nd Oct 20179:56 amRNSTotal Voting Rights
29th Sep 20174:58 pmRNSHolding(s) in Company
29th Sep 20174:10 pmRNSAcquisition
27th Sep 20174:16 pmRNSHolding(s) in Company
27th Sep 20173:49 pmRNSHolding(s) in Company
19th Sep 20178:28 amRNSHolding(s) in Company
18th Sep 20177:00 amRNS33 Suites in Clarion Hotel Liffey Valley
13th Sep 20178:51 amRNSHolding(s) in Company
5th Sep 20172:32 pmRNSDirector/PDMR Shareholding
5th Sep 20177:00 amRNSHalf-year Report
1st Sep 20177:57 amRNSTotal Voting Rights
29th Aug 201712:54 pmRNSAcquisition Update
11th Aug 20173:18 pmRNSSale & Leaseback of Hotel La Tour (Birmingham)
3rd Aug 20177:00 amRNSNotice of Results
31st Jul 201710:12 amRNSTotal Voting Rights
21st Jul 20171:56 pmRNSDalata Acquires Hotel La Tour (Birmingham) Ltd
18th Jul 20177:00 amRNSPlanning Application for Tara Towers Site
3rd Jul 20177:02 amRNSDalata Sells Leasehold Interest
30th Jun 20179:48 amRNSTotal Voting Rights
28th Jun 20178:35 amRNSHolding(s) in Company
22nd Jun 201712:00 pmRNSSale and Leaseback transaction
7th Jun 20177:00 amRNSSale & Leaseback Transaction
2nd Jun 20173:00 pmRNSDirector/PDMR Shareholding
30th May 20175:55 pmRNSHolding(s) in Company -
26th May 201710:10 amRNSHolding(s) in Company
26th May 20178:56 amRNSTotal Voting Rights
26th May 20177:00 amRNSDirector/PDMR Shareholding
18th May 20177:00 amRNSAcquisition
18th May 20177:00 amRNSAcquisition
10th May 20174:55 pmRNSResult of AGM
10th May 20177:00 amRNSAGM Statement
11th Apr 20177:00 amRNSMain Securities Market Notice
10th Apr 20172:30 pmRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.